Category «Ulcerative Colitis»

7 Alternative Therapies to Help Manage Ulcerative Colitis

Should You Try Complementary Treatment for Ulcerative Colitis? Finding the right treatment for ulcerative colitis — the right combination of medications in the correct doses — is key to getting your symptoms under control and putting the disease into remission. Some people find that adding alternative therapies to their treatment plan helps provide additional relief. Could a …

IBD Patients, Especially Those with Crohn’s, at Higher Risk of Thyroid Cancer, Study Finds

Patients with Crohn’s disease (CD) are at increased risk for developing thyroid cancer, although all inflammatory bowel disease patients show a “prevalence” for this cancer, a new study reports. The research, which com drew on evidence that people with inflammatory bowel disease (IBD) are at an increased risk of colorectal cancer (CRC), primarily as the result of chronic intestinal inflammation. Findings …

Low vitamin D levels may increase the risk of ulcerative colitis relapse

A recent study published in the journal Clinical Gastroenterology and Hepatology discovered that higher vitamin D levels may reduce the risk of relapse among ulcerative colitis patients. Ulcerative colitis is a chronic, inflammatory bowel disease (IBD) characterized by inflammation in the large intestine, also known as the colon. The inflammation causes the lining of the …

4 Reasons Why IBD Causes Fatigue

Understanding Crohn’s Disease & Ulcerative Colitis Symptoms Fatigue is a very non-specific symptom of many diseases and disorders. Feeling tired could also simply be the result of not getting enough sleep, or not getting enough quality sleep. In the U.S., we are constantly shortchanging ourselves on sleep, and most children and adults do not get …

1st Patient Enrolls in Phase 2 Study of Oral Therapy, OPRX-106, for Ulcerative Colitis

Protalix BioTherapeutics recently announced that the first patient has been enrolled in the Phase 2 clinical trial evaluating the safety, efficacy and properties of its lead drug candidate, OPRX-106, for the treatment ulcerative colitis (UC), the company announced in a press release. The proof of concept, randomized, open label Phase 2 study (NCT02768974) will evaluate the safety,  efficacy …

2% of UAE population suffer from Ulcerative Colitis and Crohn’s Disease

(MENAFN Press) A senior gastroenterologist in the UAE has warned that around 2% of UAE population suffer from Ulcerative Colitis and Crohn’s Disease, these statistics were revealed at a healthcare media roundtable hosted by Takeda Pharmaceutical Company FZCO to announce the availability of the monoclonal antibody, Vedolizumab, the first and only gut-selective biologic approved for …